Eli Lilly's Options Activity Analysis
Eli Lilly has recently caught the attention of investors as distinctive bearish activity has been observed among financial giants. By analyzing options history for Eli Lilly (NYSE: LLY), we discovered a total of 84 unusual trades that reflect diverse market sentiments.
Current Market Sentiment
In examining this trading activity, it's evident that 27% of traders exhibited a bullish outlook, while a significant 51% leaned bearish. The trades consisted of 26 puts valued at $2,090,541, and 58 calls worth an impressive $10,418,102.
Price Movement Expectations
Considering the trading volume and open interest on these options, it appears that major investors are anticipating Eli Lilly's price to fluctuate within the ranges of $520.0 to $1400.0 over the last three months. This range provides a comprehensive view of potential price actions that traders are keenly observing.
Volume and Open Interest Insights
Monitoring both volume and open interest is a reliable approach for conducting due diligence on Eli Lilly's stock. Analyzing this data facilitates the tracking of liquidity and interest regarding the options corresponding to specific strike prices.
Recent Activity Overview
In the past 30 days, the volume and open interest surrounding Eli Lilly’s options have seen notable variations within the established strike price range of $520.0 to $1400.0. The following sections provide valuable insights into this trading landscape.
Summary of Options Activity
Here is a concise summary of options activity for Eli Lilly:
- LLY Call: A striking example indicates a trade executed with a sentiment categorized as neutral, where the traded price was noted at $248.0 against an ask of $253.0.
- Another notable bearish call revealed an executed trade priced at $152.0 amidst a backdrop of fluctuating market conditions.
- A more bullish scenario for $164.24 was noted, aligning with a target indicated by an average of ratings from experts, optimizing the stock evaluation.
About Eli Lilly
Eli Lilly is a leading pharmaceutical company specializing in areas such as neuroscience, cancer, cardiometabolic, and immunology. The company’s product lineup includes Verzenio for oncology, Mounjaro, Jardiance, and Trulicity for managing cardiometabolic disorders, alongside Taltz and Olumiant for immunological treatments.
Current Stock Performance
The company’s current stock performance indicates a trading volume of 1,643,178, showing a decrease of 2.73% at $1074.19. The RSI indicators are hinting that the stock might be experiencing an overbought status.
Analysts’ Perspectives on Eli Lilly
Several experts have been vocal regarding Eli Lilly’s stock opportunities. Recently, five analysts have released their ratings with an average target price of $1195.8. Here’s some insight:
- Citigroup maintains a Buy rating, targeting a price of $1500.
- Leerink Partners upgraded their stance to Outperform, adjusting their target to $1104.
- BMO Capital sustains an Outperform rating with a $1100 target.
- Morgan Stanley keeps an Overweight rating, eyes a price of $1290.
- Cantor Fitzgerald holds an Overweight rating, targeting $985.
Risk Considerations in Options Trading
When it comes to options trading, it is essential to recognize that they pose greater risks compared to straightforward stock trading. However, they also offer higher profit potentials. To navigate this landscape, traders should focus on education, scaling their involvement in trades, and utilizing multiple indicators while closely monitoring the market trends.
Stay Updated
If you are interested in keeping abreast of the latest in options trading for Eli Lilly, there are real-time options trades alerts available through dedicated platforms, ensuring you're well-informed in this dynamic environment.
Frequently Asked Questions
What unusual options activity has been observed for Eli Lilly?
Recent analysis shows 84 notable trades, with a significant portion being bearish in nature.
What are the expectations regarding Eli Lilly's stock price?
Major investors are targeting a price range between $520.0 to $1400.0 in the coming months.
What do the analysts say about Eli Lilly's stock?
Analysts have an average target price of $1195.8 with several maintaining bullish stances.
How much is Eli Lilly's stock trading currently?
As of now, Eli Lilly's stock is trading at $1074.19 with a noted decrease of 2.73%.
What strategies are recommended for options trading?
Educating oneself, managing risk, and closely following market trends are vital for success in options trading.